Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Insights into Soluble Toll-Like Receptor 2 as a Downregulator of Virally Induced Inflammation.

Henrick BM, Yao XD, Taha AY, German JB, Rosenthal KL.

Front Immunol. 2016 Aug 2;7:291. doi: 10.3389/fimmu.2016.00291. Review.

2.

The history of fever, leukocytic pyrogen and interleukin-1.

Dinarello CA.

Temperature (Austin). 2015 Apr 14;2(1):8-16. doi: 10.1080/23328940.2015.1017086.

3.

A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza.

Piao W, Shirey KA, Ru LW, Lai W, Szmacinski H, Snyder GA, Sundberg EJ, Lakowicz JR, Vogel SN, Toshchakov VY.

Cell Rep. 2015 Jun 30;11(12):1941-52. doi: 10.1016/j.celrep.2015.05.035.

4.

The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity.

Ramirez-Ortiz ZG, Prasad A, Griffith JW, Pendergraft WF 3rd, Cowley GS, Root DE, Tai M, Luster AD, El Khoury J, Hacohen N, Means TK.

Nat Immunol. 2015 May;16(5):495-504. doi: 10.1038/ni.3143.

5.

Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis.

Saeed U, Mazoor S, Jalal N, Zahid Piracha Z.

Jundishapur J Microbiol. 2014 Dec 6;8(1):e13348. doi: 10.5812/jjm.13348.

PMID:
25763131
Free PMC Article
6.

MyD88: a central player in innate immune signaling.

Deguine J, Barton GM.

F1000Prime Rep. 2014 Nov 4;6:97. doi: 10.12703/P6-97. Review.

7.

Interferon induction by RNA viruses and antagonism by viral pathogens.

Nan Y, Nan G, Zhang YJ.

Viruses. 2014 Dec 12;6(12):4999-5027. doi: 10.3390/v6124999. Review.

8.

Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

White AF, Demchenko AV.

Adv Carbohydr Chem Biochem. 2014;71:339-89. doi: 10.1016/B978-0-12-800128-8.00005-4. Review.

9.

Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.

Wang JQ, Jeelall YS, Ferguson LL, Horikawa K.

Front Immunol. 2014 Jul 31;5:367. doi: 10.3389/fimmu.2014.00367. Review.

10.

Negative regulation of Toll-like receptor-4 signaling through the binding of glycosylphosphatidylinositol-anchored glycoprotein, CD14, with the sialic acid-binding lectin, CD33.

Ishida A, Akita K, Mori Y, Tanida S, Toda M, Inoue M, Nakada H.

J Biol Chem. 2014 Sep 5;289(36):25341-50. doi: 10.1074/jbc.M113.523480.

11.

Differential Expression of Th1- and Th2- Type Cytokines in Peripheral Blood Mononuclear Cells of Murrah Buffalo (Bubalus Bubalis) on TLR2 Induction by B. Subtilis Peptidoglycan.

Shah SM, Ravi Kumar GV, Brah GS, Santra L, Pawar H.

Asian-Australas J Anim Sci. 2012 Jul;25(7):1021-8. doi: 10.5713/ajas.2012.12033.

12.

Structure of the Toll-Spatzle complex, a molecular hub in Drosophila development and innate immunity.

Parthier C, Stelter M, Ursel C, Fandrich U, Lilie H, Breithaupt C, Stubbs MT.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6281-6. doi: 10.1073/pnas.1320678111.

13.

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.

Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT.

Front Immunol. 2013 Sep 17;4:280. doi: 10.3389/fimmu.2013.00280. Review.

14.

Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology.

Mahla RS, Reddy MC, Prasad DV, Kumar H.

Front Immunol. 2013 Sep 2;4:248. doi: 10.3389/fimmu.2013.00248. Review.

15.

Innate immune recognition of the microbiota promotes host-microbial symbiosis.

Chu H, Mazmanian SK.

Nat Immunol. 2013 Jul;14(7):668-75. doi: 10.1038/ni.2635. Review.

16.

Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent.

Rogers EN, Jones DZ, Kidd NC, Yeyeodu S, Brock G, Ragin C, Jackson M, McFarlane-Anderson N, Tulloch-Reid M, Sean Kimbro K, Kidd LR.

Genes Immun. 2013 Sep;14(6):347-55. doi: 10.1038/gene.2013.22.

17.

Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal).

Bovijn C, Desmet AS, Uyttendaele I, Van Acker T, Tavernier J, Peelman F.

J Biol Chem. 2013 Apr 26;288(17):12054-66. doi: 10.1074/jbc.M112.415810.

18.

Suppression of TLR signaling by targeting TIR domain-containing proteins.

Fekonja O, Avbelj M, Jerala R.

Curr Protein Pept Sci. 2012 Dec;13(8):776-88. Review.

19.

Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans.

von Bernuth H, Picard C, Puel A, Casanova JL.

Eur J Immunol. 2012 Dec;42(12):3126-35. doi: 10.1002/eji.201242683. Review.

20.

Functional insights from the crystal structure of the N-terminal domain of the prototypical toll receptor.

Gangloff M, Arnot CJ, Lewis M, Gay NJ.

Structure. 2013 Jan 8;21(1):143-53. doi: 10.1016/j.str.2012.11.003.

Items per page

Supplemental Content

Support Center